339 related articles for article (PubMed ID: 20030791)
1. Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.
Tonnetti L; Proctor MC; Reddy HL; Goodrich RP; Leiby DA
Transfusion; 2010 May; 50(5):1019-27. PubMed ID: 20030791
[TBL] [Abstract][Full Text] [Related]
2. Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.
Tonnetti L; Thorp AM; Reddy HL; Keil SD; Goodrich RP; Leiby DA
Transfusion; 2013 Apr; 53(4):860-7. PubMed ID: 22803831
[TBL] [Abstract][Full Text] [Related]
3. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.
Grellier P; Benach J; Labaied M; Charneau S; Gil H; Monsalve G; Alfonso R; Sawyer L; Lin L; Steiert M; Dupuis K
Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613
[TBL] [Abstract][Full Text] [Related]
4. Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates.
Ambruso DR; Thurman G; Marschner S; Goodrich RP
Transfusion; 2009 Dec; 49(12):2631-6. PubMed ID: 19694996
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
6. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study.
Picker SM; Steisel A; Gathof BS
Transfus Apher Sci; 2009 Apr; 40(2):79-85. PubMed ID: 19233725
[TBL] [Abstract][Full Text] [Related]
7. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.
Cardo LJ; Rentas FJ; Ketchum L; Salata J; Harman R; Melvin W; Weina PJ; Mendez J; Reddy H; Goodrich R
Vox Sang; 2006 Feb; 90(2):85-91. PubMed ID: 16430665
[TBL] [Abstract][Full Text] [Related]
8. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units.
Picker SM; Steisel A; Gathof BS
Transfusion; 2008 Aug; 48(8):1685-92. PubMed ID: 18513255
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of Babesia microti in red blood cells and platelet concentrates.
Tonnetti L; Laughhunn A; Thorp AM; Vasilyeva I; Dupuis K; Stassinopoulos A; Stramer SL
Transfusion; 2017 Oct; 57(10):2404-2412. PubMed ID: 28872685
[TBL] [Abstract][Full Text] [Related]
10. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
[TBL] [Abstract][Full Text] [Related]
11. Cell quality of apheresis-derived platelets treated with riboflavin-ultraviolet light after resuspension in platelet additive solution.
Picker SM; Tauszig ME; Gathof BS
Transfusion; 2012 Mar; 52(3):510-6. PubMed ID: 21981030
[TBL] [Abstract][Full Text] [Related]
12. Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction.
Picker SM; Oustianskaia L; Schneider V; Gathof BS
Vox Sang; 2009 Jul; 97(1):26-33. PubMed ID: 19302416
[TBL] [Abstract][Full Text] [Related]
13. Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system.
Vanlandingham DL; Keil SD; Horne KM; Pyles R; Goodrich RP; Higgs S
Transfusion; 2013 Feb; 53(2):284-90. PubMed ID: 22626525
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.
Li J; Lockerbie O; de Korte D; Rice J; McLean R; Goodrich RP
Transfusion; 2005 Jun; 45(6):920-6. PubMed ID: 15934990
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction.
AuBuchon JP; Herschel L; Roger J; Taylor H; Whitley P; Li J; Edrich R; Goodrich RP
Transfusion; 2005 Aug; 45(8):1335-41. PubMed ID: 16078923
[TBL] [Abstract][Full Text] [Related]
16. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
Smith J; Rock G
Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
[TBL] [Abstract][Full Text] [Related]
17. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.
Bihm DJ; Ettinger A; Buytaert-Hoefen KA; Hendrix BK; Maldonado-Codina G; Rock G; Giclas PC; Goodrich RP
Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460
[TBL] [Abstract][Full Text] [Related]
18. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.
Goodrich RP; Edrich RA; Li J; Seghatchian J
Transfus Apher Sci; 2006 Aug; 35(1):5-17. PubMed ID: 16935562
[TBL] [Abstract][Full Text] [Related]
19. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.
Cardo LJ; Salata J; Mendez J; Reddy H; Goodrich R
Transfus Apher Sci; 2007 Oct; 37(2):131-7. PubMed ID: 17950672
[TBL] [Abstract][Full Text] [Related]
20. Transfusion-transmitted Babesia microti identified through hemovigilance.
Tonnetti L; Eder AF; Dy B; Kennedy J; Pisciotto P; Benjamin RJ; Leiby DA
Transfusion; 2009 Dec; 49(12):2557-63. PubMed ID: 19624607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
